secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATAI Life Sciences N.V. (—)
CIK:        0001840904
Form:       8-K
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0001140361-24-003285
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ATAI acquires additional ~11.2M shares in Beckley Psytech for $10M, raising stake to 35.47%
--------------------------------------------------------------------------------

- Secondary purchase of 11,153,246 shares from existing shareholders at ~$0.8966/share, total $10M.
- Combined with Jan 3 primary investment of $40M for 24.1M Series C shares, total outlay ~$50M.
- ATAI now holds a 35.47% voting interest in Beckley Psytech Limited.
- All acquired shares re-designated as Series C preferred shares; investment closed on Jan 18, 2024.
- Transaction structured via Share Purchase Deed; warrants customary representations from sellers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840904/000114036124003285/0001140361-24-003285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840904/000114036124003285/ef20019485_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-003285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer